AVROBIO, Inc. Gains 45.96%

Wed, Jul 12, 2023 at 07:38 PM

AVROBIO, Inc. (AVRO:NASDAQ) soared at $1.43, a gain of 46%. On Wed, Jul 12, 2023, AVRO:NASDAQ touched a New 2-Week High of $1.43. From Wed, Jun 28, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days

The stock spiked on Mon, May 22, 2023 at $1.7 with a volume of 85M+.

About AVROBIO, Inc. (AVRO:NASDAQ)

Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.

Top 10 Gainers:

Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 93.37%
The NFT Gaming Company Inc. (NFTG:NASDAQ), 90.07%
Recursion Pharmaceuticals Inc. (RXRX:NASDAQ), 78.17%
Ault Alliance Inc Com (AULT:NYSEMKT), 60.91%
Freeline Therapeutics Holdings plc (FRLN:NASDAQ), 54.99%
Camber Energy, Inc. (CEI:NYSEMKT), 48.91%
InspireMD Inc. (NSPR:NASDAQ), 46.52%
AVROBIO, Inc. (AVRO:NASDAQ), 45.96%
Elys Game Technology Corp. (ELYS:NASDAQ), 43.7%
Liminal BioSciences Inc. (LMNL:NASDAQ), 40%